Non-Cytologic Cervical Screening Is Cost-Effective – NEJM Study
This article was originally published in The Gray Sheet
Executive Summary
Strategies such as visual inspection of the cervix or the use of human papillomavirus assays that require only one or two clinical visits are cost-effective alternatives to conventional three-visit cytology-based screening in low-resource settings, according to a study published in the Nov. 17 New England Journal of Medicine
You may also be interested in...
One-Stop Cervical Cancer Screening And Treatment May Improve Care – JAMA
The "screen-and-treat" approach to cervical cancer could stem the spread of the disease in areas with few medical resources, according to two studies published in the Nov. 2 issue of the Journal of the American Medical Association
Cervical Imaging Device Prompts FDA Panel Concern With False Positives
FDA's Obstetrics & Gynecology Devices Panel concluded May 17 that MediSpectra's pivotal studies failed to show a statistically significant benefit for the Luma cervical imager
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.